CONDITIONS TREATeD / TYPE 2 DIABETES
Regenerate. Repair. Restore.
Stem Cells Therapy for Type 2 Diabetes Mellitus
WHAT IS STEM CELL THERAPY?
HOW STEM CELL THERAPY WILL HELP?
WHAT SETS US APART?
WHY STEM CELLS TRANSPLANT INSTITUTE?
Type 2 diabetes is the most common form.
Treatment at the Stem Cells Transplant Institute could help improve the following symptoms of type 2 diabetes:
- Excessive thirst
- Frequent Urination
- Excessive hunger
- Fatigue
- Blurred Vision
- Unexplained weight loss
- Irritability
- Frequent infections
- Slow healing sores (e.g. gum infections, vaginal infections)
- Dizziness
What do we know about type 2 diabetes?
Type 2 diabetes is a long-term condition that impairs your glucose metabolism. Pancreas makes insulin, a hormone that transports glucose into your cells to be used as energy. Insulin works by lowering the amount of sugar in your blood stream, while the pancreas slows the production and release of insulin when your blood sugar drops.
Insulin resistance is the initial symptom of type 2 diabetes, which means your body resists the effects of insulin. In response, your pancreas produces more insulin to get the sugar into the cells. Eventually, when the pancreas can no longer keep up, glucose builds up in the blood.
The beta cells in the pancreas are responsible for producing insulin. They work harder to produce enough insulin to transport the sugar into the cells, but the beta cells eventually break down, transmitting the wrong amount of insulin at the wrong time.
Over time, your beta cells may wear out completely, and you will no longer be able to produce any insulin.
Sugar (glucose) is the main source of energy for cells. Glucose comes from food and is also produced in your liver.
Your liver stores and produces glucose. When your body needs more sugar, it signals the liver to produce and send out more glucose, which keeps your blood sugar within a normal range.
The sugar from your food is used and the liver slows down the production of sugar and stores any excess sugar from the food you ate. In type 2 diabetes patients, this mechanism can fail, causing the liver to continue to send sugar into the blood stream.
Many patients with type 2 diabetes suffers with metabolic syndrome. A medical term used to describe a group of conditions including hyperglycemia, high blood pressure, high cholesterol and high triglycerides.
Serious complications caused by type 2 diabetes:
- Organ damage including damage to the heart, kidneys, eyes, blood vessels and nerves
- Heart attack and/or stroke
- Foot ulcers, infection and limb amputation
- Blindness
- Kidney failure
- Current standard care therapies are unable to reverse type 2 diabetes.
Why should I consider stem cell therapy?
Why should I consider stem cell therapy?
Researchers have shown mesenchymal stem cells (MSCs) have the potential to treat many chronic diseases, including type 2 diabetes.
MSCs have the ability to differentiate, self-renew, suppress the immune system, reduce inflammation, repair tissue, and are considered an ideal choice for the treatment of type 2 diabetes.1
Mesenchymal stem cells have the ability to:
- Differentiate into insulin producing cells
- Regenerate and protect pancreatic cells
- Restore beta cell function and mass
- Convert alpha cell to beta cells
- Reduce inflammation and insulin resistance
What is the recommended treatment protocol for type 2 diabetes at the Stem Cells Transplant Institute?
The Stem Cells Transplant Institute uses mesenchymal stem cells for the treatment of type 2 diabetes. Mesenchymal stem cells have a number of advantages over other types of stem cells, including the ability to migrate to sites of tissue injury, a strong immunosuppressive effect, and better safety after infusion.
For optimal results, the Stem Cells Transplant Institute recommends a one-day treatment with human umbilical cord stem cells (hUC-MSCs) for type 2 diabetes. If the patient prefers, autologous stem cells from their own adipose tissue or bone marrow can be used. Both treatments will include the following:
Antioxidant therapy with vitamin C and glutathione- Ozone therapy
- Platelet-rich plasma therapy (PRP)
Mesenchymal stem cells are a promising treatment for diabetes mellitus. Treatment at the Stem Cells Transplant Institute may improve the symptoms and long-term complications of type 2 diabetes.
UMBILICAL CORD DONATIONS
How Are the Stem Cells Collected?
Our clinic focuses on obtaining healthy stem cells exclusively from umbilical cord blood donors. We collect the placenta once the baby is born, with the parent’s informed consent. Additionally, we follow strict ethical guidelines and collect stem cells from reliable and reputable sources.
INTRAVENUS ADMINISTRATION
How Are the Stem Cells Administered?
Our nursing staff administers the stem cells through an intravenous and intra-pulmonary route. For the most effective outcomes, intravenous administration is preferred.
Please fill this form
Scientific References:
- Fu et al. Stem cell transplantation therapy in Parkinson’s disease. SpringerPlus (2015) 4:597
- Joyce et al. Mesenchymal stem cell for the treatment of neurodegenerative disease. Regen Med. 2010, November, 5(6)933-946. Doi:10.2217/rme.10.72
- Helena Vilaça-Faria, António J. Salgado and Fábio G.
- Teixeira Mesenchymal Stem Cells-derived Exosomes: A New Possible Therapeutic Strategy for Parkinson’s disease. Cells2019, 8(2), 118; doi:3390/cells8020118
Teixeira, F.G.; Carvalho, M.M.; Neves-Carvalho, A.; Panchalingam, K.M.; Behie, L.A.; Pinto, L.; Sousa, N.; Salgado, A.J. Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev.2015, 11, 288–297. [Google Scholar] [CrossRef] [PubMed] - Gao, F.; Chiu, S.M.; Motan, D.A.; Zhang, Z.; Chen, L.; Ji, H.L.; Tse, H.F.; Fu, Q.L.; Lian, Q. Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis.2016, 7, e2062. [Google Scholar] [CrossRef] [PubMed]
- Joyce, N.; Annett, G.; Wirthlin, L.; Olson, S.; Bauer, G.; Nolta, J.A. Mesenchymal stem cells for the treatment of neurodegenerative disease. Med.2010, 5, 933–946. [Google Scholar] [CrossRef] [PubMed]
- Fraga, J.S.; Silva, N.A.; Lourenco, A.S.; Goncalves, V.; Neves, N.M.; Reis, R.L.; Rodrigues, A.J.; Manadas, B.; Sousa, N.; Salgado, A.J. Unveiling the effects of the secretome of mesenchymal progenitors from the umbilical cord in different neuronal cell populations. Biochimie2013, 95, 2297–2303. [Google Scholar] [CrossRef] [PubMed]
- Ribeiro, C.A.; Fraga, J.S.; Graos, M.; Neves, N.M.; Reis, R.L.; Gimble, J.M.; Sousa, N.; Salgado, A.J. The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res. Ther.2012, 3, 18. [Google Scholar] [CrossRef]
- Ribeiro, C.A.; Salgado, A.J.; Fraga, J.S.; Silva, N.A.; Reis, R.L.; Sousa, N. The secretome of bone marrow mesenchymal stem cells-conditioned media varies with time and drives a distinct effect on mature neurons and glial cells (primary cultures). Tissue Eng. Regen. Med.2011, 5, 668–672. [Google Scholar] [CrossRef]
- Salgado, A.J.; Fraga, J.S.; Mesquita, A.R.; Neves, N.M.; Reis, R.L.; Sousa, N. Role of human umbilical cord mesenchymal progenitors conditioned media in neuronal/glial cell densities, viability, and proliferation. Stem Cells Dev.2010, 19, 1067–1074. [Google Scholar] [CrossRef]
- Martins, L.F.; Costa, R.O.; Pedro, J.R.; Aguiar, P.; Serra, S.C.; Teixeira, F.G.; Sousa, N.; Salgado, A.J.; Almeida, R.D. Mesenchymal stem cells secretome-induced axonal outgrowth is mediated by BDNF. Rep.2017, 7, 4153. [Google Scholar] [CrossRef]
- Serra, S.C.; Costa, J.C.; Assuncao-Silva, R.C.; Teixeira, F.G.; Silva, N.A.; Anjo, S.I.; Manadas, B.; Gimble, J.M.; Behie, L.A.; Salgado, A.J. Influence of passage number on the impact of the secretome of adipose tissue stem cells on neural survival, neurodifferentiation and axonal growth. Biochimie2018, 155, 119–128. [Google Scholar] [CrossRef]
- Assuncao-Silva, R.C.; Mendes-Pinheiro, B.; Patricio, P.; Behie, L.A.; Teixeira, F.G.; Pinto, L.; Salgado, A.J. Exploiting the impact of the secretome of MSCs isolated from different tissue sources on neuronal differentiation and axonal growth. Biochimie2018, 155, 83–91. [Google Scholar] [CrossRef] [PubMed]
